These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Trends in zidovudine prescription since 1987 in AIDS-free HIV-positive French patients attending university hospitals. Guiguet M; Mary M; Costagliola D; Armengaud M; Cartier F; Micoud M; Mouton Y; Sobesky G; Valleron AJ AIDS; 1992 Nov; 6(11):1405-6. PubMed ID: 1361751 [No Abstract] [Full Text] [Related]
4. Zidovudine for symptomless HIV infection. Lancet; 1990 Apr; 335(8693):821-2. PubMed ID: 1969561 [No Abstract] [Full Text] [Related]
6. The effect of zidovudine on neuropsychiatric measures in HIV-infected men. Gorman JM; Mayeux R; Stern Y; Williams JB; Rabkin J; Goetz RR; Ehrhardt AA Am J Psychiatry; 1993 Mar; 150(3):505-7. PubMed ID: 8094601 [TBL] [Abstract][Full Text] [Related]
7. [Controversies concerning the use of zidovudine in the treatment of asymptomatic HIV+ subjects with a low number of CD4+ lymphocytes]. Sarmati L; Vella S; Rocchi G Medicina (Firenze); 1990; 10(2):195-7. PubMed ID: 2273959 [No Abstract] [Full Text] [Related]
9. Preliminary analysis of the Concorde trial. Concorde Coordinating Committee. Aboulker JP; Swart AM Lancet; 1993 Apr; 341(8849):889-90. PubMed ID: 8096582 [No Abstract] [Full Text] [Related]
10. Zidovudine response relationships in early human immunodeficiency virus infection. Sale M; Sheiner LB; Volberding P; Blaschke TF Clin Pharmacol Ther; 1993 Nov; 54(5):556-66. PubMed ID: 7900949 [TBL] [Abstract][Full Text] [Related]
11. Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Duvic M; Crane MM; Conant M; Mahoney SE; Reveille JD; Lehrman SN Arch Dermatol; 1994 Apr; 130(4):447-51. PubMed ID: 7909423 [TBL] [Abstract][Full Text] [Related]
12. The Concorde zidovudine trial and antiretroviral strategies for asymptomatic patients. Goldschmidt RH J Am Board Fam Pract; 1993; 6(6):604-6. PubMed ID: 7904416 [No Abstract] [Full Text] [Related]
13. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group. Koch MA; Volberding PA; Lagakos SW; Booth DK; Pettinelli C; Myers MW Arch Intern Med; 1992 Nov; 152(11):2286-92. PubMed ID: 1359846 [TBL] [Abstract][Full Text] [Related]
14. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee. Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442 [TBL] [Abstract][Full Text] [Related]
15. Zidovudine in symptomless HIV infection. Lancet; 1989 Feb; 1(8635):415-6. PubMed ID: 2563790 [No Abstract] [Full Text] [Related]
16. [What attitude to take in symptomless HIV infection?]. Seligmann M Pathol Biol (Paris); 1992 Nov; 39(9):879-80. PubMed ID: 1538918 [No Abstract] [Full Text] [Related]
17. The Concorde trial. Danner SA Lancet; 1993 May; 341(8855):1276. PubMed ID: 8098407 [No Abstract] [Full Text] [Related]
19. Management of the HIV-infected patient. Bryan CS; Postic B J S C Med Assoc; 1988 Sep; 84(9):437-43. PubMed ID: 2903271 [No Abstract] [Full Text] [Related]
20. The Concorde trial. Green G Lancet; 1993 May; 341(8855):1276-7. PubMed ID: 8098409 [No Abstract] [Full Text] [Related] [Next] [New Search]